Price
CHART BY
Frequently asked questions
What is IQVIA Hldgs's market capitalization?
What is IQVIA Hldgs's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for IQVIA Hldgs?
What are the analyst ratings and target price for IQVIA Hldgs's stock?
What is IQVIA Hldgs's revenue over the trailing twelve months?
What is the EBITDA for IQVIA Hldgs?
What is the free cash flow of IQVIA Hldgs?
How many employees does IQVIA Hldgs have, and what sector and industry does it belong to?
What is the free float of IQVIA Hldgs's shares?
Financials
- Market Cap
- $35.80B
- EPS (TTM)
- $7.624
- Free Float
- 180.00M
- P/E ratio (TTM)
- 25.87
- Revenue (TTM)
- $15.31B
- EBITDA (TTM)
- $3.29B
- Free Cashflow (TTM)
- $1.96B
Pricing
- 1D span
- $190.09$200.19
- 52W span
- $187.79$261.66
Analyst Ratings
The price target is $247.77 and the stock is covered by 28 analysts.
Buy
24
Hold
4
Sell
0
Information
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
- Employees
- 87,000
- Industries
- Services to the Health Industry
- Sector
- Health Care
Identifier
- ISIN
- US46266C1053
- Primary Ticker
- IQV